Arexis Gets EU Funding for a Clinical Study on Improved Nutrition in Pre-term Infants GOTHENBURG, Sweden, Sept. 22, 2004 (PRIMEZONE) -- The Gothenburg-based drug development company Arexis AB today announced that its novel project on bile salt-stimulated lipase (BSSL), an enzyme...

Arexis acquires project in lipid metabolism GOTHENBURG, Sweden, Feb. 17, 2004 (PRIMEZONE) -- Arexis has acquired a project concerning human bile salt stimulated lipase, BSSL, from AstraZeneca. The aim of the project is to develop a new type of...

Arexis AB has Today Initiated a Phase II Clinical Study in the Area of Lipid Metabolism GOTHENBURG, Sweden, July 8, 2003 (PRIMEZONE) -- Arexis AB has today initiated a phase II clinical study in the area of lipid metabolism. The study will be completed before the end of this year....

Swedish Drug Discovery Company Arexis AB Raises SEK 63 Million GOTHENBURG, Sweden, July 01, 2003 (PRIMEZONE) -- Swedish drug discovery company Arexis AB raises SEK 63 million Arexis AB today announced the completion of a 63 million SEK private placement in...

Arexis: Patent Approval for Treating Common Skin Disorders STOCKHOLM, Sweden, Feb. 12, 2003 (PRIMEZONE) -- Arexis AB has received approval for a breakthrough patent application in Europe, covering a new method for treating the most common skin disorders. The...